PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction

NCT05709626 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

2258

Enrollment

OTHER

Sponsor class

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

DRUG: No aspirin (Prasugurel monotherapy)
DRUG: 12-month DAPT

Sponsor

Kindai University

Collaborators

[object Object]